Optics-free Imaging
for Drug Discovery
Real-time, high resolution, live-cell assays
using our electronic platform
CMOS-powered
Measurement
and Manipulation
By designing and developing cell culture plates with embedded high-density electronic systems, our technology will accelerate the drug discovery pipeline in broad therapeutic areas towards the IND stage (Investigational New Drug Application).
Kinetics
Investigate mechanism of actions, cellular growth and death, or movement
Cell Manipulation
Create customized wound healing assays or form repeatable co-cultures
Barrier Function
Perform spatial TEER measurements to accurately assess cell-cell junction integrity
Redox Metabolism
Visualize metabolic state of cells, investigate oxidative stress, antioxidant capacity, or mechanism of cell-death
Electrophysiology
Measure & stimulate the electrical signals of excitable cells such as cardiomyocytes or neurons
Multi-parametric
Combining cell kinetics, barrier function, metabolic state, electrophysiology measurements and manipulations from the same cell culture
Live-cell
Delivering non-invasive and label free measurements through the whole duration of the assay – quality data extracted from living cells as they culture
High-resolution
Generating optics-free images to understand what is happening down to a single cell – overcome traditional whole-well aggregate readouts
News and Publications
Funding Announced (2022)
CytoTronics Launches with $9.25 Million in Seed Funding to Revolutionize Drug Discovery and Phenotypic Screening
Lab on a Chip (2022)
Multi-parametric functional imaging of cell cultures and tissues with a CMOS microelectrode array
Nature Biomedical Engineering (2020)
A nanoelectrode array for obtaining intracellular recordings from thousands of connected neurons
IEEE Journal of Solid-State Circuits (2020)
CMOS nanoelectrode array for intracellular recording and stimulation of mammalian neurons
Nature Nanotech (2017)
CMOS nanoelectrode array for all-electrical intracellular electrophysiological imaging
Our Team
Spinning out of Harvard University, CytoTronics is building the next generation of complementary metal-oxide-semiconductor (CMOS) electronics technology for cell measurement and manipulation.
Operating Team
Board of Directors
Advisors
Operating Team
Jeffrey Abbott, PhD
Co-founder & CEO
Alexander Alexeyev
Head of Electrical Engineering
Mickey Cheah
Senior ASIC Design Engineer
Lori Cirella
Finance Manager
Hendrick Melo
VP of Software Development
Brendan Powers
Principal Software Engineer
Duane Sword
Co-founder & CBO
Vince Wu, PhD
Co-founder & CTO
Board of Directors
Jeffrey Abbott, PhD
Co-founder & CEO
Jenna Abelli
Principal, Anzu Partners
Douglas Kahn
Executive Chariman, CytoTronics Former CEO & Chairman, TetraGenetics (acquired by AbCellera)
Tayo Sanders, PhD
Board Observer Investor, Anzu Partners
Duane Sword
Co-founder & CBO
Vince Wu, PhD
Co-founder & CTO
Advisors
Scientific Co-Founders
Donhee Ham, PhD
Harvard Professor of Electrical Engineering & Applied Physics
Hongkun Park, PhD
Harvard Professor of Physics & Chemistry
Advisors
Milad Alucozai
Head of Bio and Deep Tech, BoxOne Ventures
Chris Brown, PhD
Co-founder and CTO, 908 Devices
William Cantley, PhD
Senior Scientist, CNS Biology, Alnylam Pharmaceuticals
Mike Cuccarese, PhD
Director Translational Oncology, Recursion
Collaborators
Avik Mukherjee, PhD
Postdoctoral Researcher, Harvard Medical School
Markus Basan, PhD
Assistant Professor, Harvard Medical School
Careers
Resume Drop for Future Opportunities
Don’t see your perfect role, but interested in developing a breakthrough technology targeting immediate drug discovery applications? We don’t want to let a job description stop you from applying and are always looking for high performers to join our team.